Axsome Therapeutics
neuroscience healthcare depression life-sciences biotechnology pharmaceuticals fibromyalgia migraine smoking-cessation narcolepsy central-nervous-system biopharmaceuticals clinical-pipeline alzheimers-disease-agitation fda-approved
-
Updated
May 23, 2026